The Radboudumc and NeLL Expertise Center for Parkinson’s complement each other well, according to those involved. For example, both conduct scientific research into how consumers and patients absorb, process and monitor health information. With the specialist knowledge from the studies of the Parkinson Center and the broad expertise of NeLL in the field of validation and implementation, both are committed to the best possible personalized care. E-Health will play a major role in this.
Patients with Parkinson’s benefit from collaboration
By jointly acquiring, collecting and sharing new knowledge, the specialists of the expertise center for Parkinson’s and NeLL want to develop sustainable, future-proof care in which care is tailored as best as possible to the individual patient. “The mission of our expertise center is to improve the quality of life for people with Parkinson’s,” says Bas Bloem of the Radboudumc Expertise Center for Parkinson’s. “I am very impressed with the vast knowledge available within NeLL. I am convinced that we will soon be able to achieve tangible results that will benefit patients.”
International platform for digital care
At NeLL they are just as enthusiastic about the cooperation of these parties that are complementary to each other. Niels Chavannes, founder of Nell: “At NeLL, we are honored to be working together with the Radboudumc Expertise Center for Parkinson’s. As a national and international knowledge platform for digital care, we can help to disseminate and implement expertise. We will also compare Parkinson’s with other relevant chronic conditions, so that we gain more insight into the best possible strategies for diagnosis and treatment.”
Parkinson & facts
In the Netherlands there were 57,960 people with Parkinson’s disease in 2020. This number is increasing mainly due to the rapid aging of the population. Trembling, slower movements and difficulty walking are some of the symptoms of Parkinson’s, a complex disease that is not always recognized at an early stage. Insight into the disease is slowly but surely increasing, but a cure is not yet possible. However, the number of treatment options is growing, for example to reduce symptoms.
A good example is the promising compact brain implant (DBS) recently developed at Oxford University. Closely in line with the collaboration between Radboudumc and NeLL, increasing attention is also being paid to home monitoring of Parkinson’s patients. Patients who are treated at Elkerliek and Zuyderland Medical Center can, for example, receive the care they used to have to go to hospital for at home since the beginning of 2022.